Mitochondrial Medicine. The GENOMIT initiative
Mitochondrial disorders have emerged as a major cause of inherited human disease.
There is a growing appreciation that new treatments will emerge through collaborations between clinicians, laboratory scientists and the life sciences industry, based on a firm understanding of the disease mechanisms.
This conference, based on the experience of the GENOMIT consortium, funded by the European Joint Programme on rare diseases, aims to bring these groups together, exploring the most recent advances in term of natural histories, artificial intelligence, clinical trial readiness and emerging treatment options in preclinical and clinical models.